Company page
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a public biotechnology company listed under the ticker NTLA on the American stock market. The company focuses on developing innovative gene-editing therapies. As of now, Intellia has a market capitalization of approximately $2.19 billion.
- Ticker
- NTLA:NASDAQ
- Asset type
- Stock
- Market cap
- $2.19B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD